China-based WuXi Biologics has agreed to build its 107,000 sqft clinical and commercial manufacturing facility in Worcester, US
WuXi Biologics and the Worcester Business Development Corporation (WBDC) have announced the signing of a land deal for WuXi Biologics' clinical and commercial manufacturing facility (MFG11) in the US. A 46-acre master-planned biomanufacturing campus.
The approximately 107,000 sqft two-story facility will be operational in 2022 and create 150 new jobs.
"As the central Massachusetts biotech community continues its growth, WuXi Biologics' arrival in Worcester will strengthen the sector and lead to ongoing economic development," said Lt Governor Karyn Polito. "Years of planning and collaboration to transform an unused property into a biomanufacturing hub has led to this exciting announcement today and I appreciate the commitment of so many to making this a reality."
"This signing solidifies our city's proud role as an anchor in the state's biotech corridor," said Worcester City Manager Edward Augustus, Jr "It signals not only what we currently have to offer in the life sciences sector, but also how much potential we have for the future."
Craig Blais, the President and CEO of the WBDC, said: "WuXi Biologics' decision to locate its first US biomanufacturing facility in Worcester at The Reactory confirms the value of Worcester's strong life sciences ecosystem. We expect other biotech manufacturers will soon follow their lead."
"We are proud to join the Worcester community and greater region as a tenant of The Reactory, and I thank the city of Worcester for its collaboration," said Dr Chris Chen, CEO of WuXi Biologics. "Drawing from the talented workforce and impressive biotech network in Massachusetts, we stand ready and able to help our global partners advance their innovative and life-saving ideas. Together, I am confident that we have much to contribute to the biologics industry and patients worldwide."
In March, recognising the urgent need for personal protective equipment (PPE), WuXi Biologics sourced and donated masks to local healthcare providers to support frontline medical personnel fighting the coronavirus.